XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues        
Operating income $ 1,323 $ 4,158 $ 2,776 $ 12,488
Operating expenses        
Research and development expenses (16,320) (25,751) (58,663) (75,214)
Sales and Marketing expenses (1,072) (1,595) (2,999) (8,114)
General and administrative expenses (8,299) (6,863) (26,250) (26,838)
Restructuring expenses   286   (21,003)
Total Operating expenses (25,691) (33,923) (87,912) (131,169)
Loss from operations (24,368) (29,765) (85,137) (118,681)
Other Income (expenses)        
Financial income (expense) 336 (1,184) 597 (1,380)
Loss before taxes (24,033) (30,948) (84,540) (120,061)
Income tax   (7) 404 (10)
Net loss (24,033) (30,955) (84,136) (120,071)
Foreign currency translation differences, net of taxes (3,728) 13,196 (9,684) 13,495
Actuarial gains (losses) on employee benefits, net of taxes 28 (75) (10) (113)
Comprehensive loss $ (27,733) $ (17,834) $ (93,830) $ (106,688)
Basic/diluted net loss per share attributable to shareholders $ (0.44) $ (0.56) $ (1.53) $ (2.23)
Weighted average shares outstanding used in computing per share amounts: 54,947,354 54,843,843 54,911,278 53,852,176